179 related articles for article (PubMed ID: 23534731)
21. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis.
Woo HD; Kim K; Kim J
Cancer Causes Control; 2015 Nov; 26(11):1661-70. PubMed ID: 26376895
[TBL] [Abstract][Full Text] [Related]
22. C-reactive protein and the risk of cancer: a mendelian randomization study.
Allin KH; Nordestgaard BG; Zacho J; Tybjaerg-Hansen A; Bojesen SE
J Natl Cancer Inst; 2010 Feb; 102(3):202-6. PubMed ID: 20056955
[TBL] [Abstract][Full Text] [Related]
23. Association between C-reactive protein level and subsequent risk of ovarian cancer: A meta-analysis of 13 cohorts in 1,852 ovarian cancer patients.
Wang Y; Zhang Z; Wang J; Zhang X
Medicine (Baltimore); 2020 Jan; 99(5):e18821. PubMed ID: 32000385
[TBL] [Abstract][Full Text] [Related]
24. Plasma C-reactive protein and risk of breast cancer in two prospective studies and a meta-analysis.
Wang J; Lee IM; Tworoger SS; Buring JE; Ridker PM; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1199-206. PubMed ID: 25994740
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein and risk of fracture: a systematic review and dose-response meta-analysis of prospective cohort studies.
Wu ZJ; He JL; Wei RQ; Liu B; Lin X; Guan J; Lan YB
Osteoporos Int; 2015 Jan; 26(1):49-57. PubMed ID: 25107320
[TBL] [Abstract][Full Text] [Related]
26. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
[TBL] [Abstract][Full Text] [Related]
27. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies.
Lahart IM; Metsios GS; Nevill AM; Carmichael AR
Acta Oncol; 2015 May; 54(5):635-54. PubMed ID: 25752971
[TBL] [Abstract][Full Text] [Related]
28. Sleep duration and cancer risk: a systematic review and meta-analysis of prospective studies.
Zhao H; Yin JY; Yang WS; Qin Q; Li TT; Shi Y; Deng Q; Wei S; Liu L; Wang X; Nie SF
Asian Pac J Cancer Prev; 2013; 14(12):7509-15. PubMed ID: 24460326
[TBL] [Abstract][Full Text] [Related]
29. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
[TBL] [Abstract][Full Text] [Related]
30. Pooled Analysis of C-Reactive Protein Levels and Mortality in Prostate Cancer Patients.
Graff JN; Beer TM; Liu B; Sonpavde G; Taioli E
Clin Genitourin Cancer; 2015 Aug; 13(4):e217-e221. PubMed ID: 25735198
[TBL] [Abstract][Full Text] [Related]
31. Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence.
Kunutsor SK; Seidu S; Blom AW; Khunti K; Laukkanen JA
Eur J Epidemiol; 2017 Aug; 32(8):657-667. PubMed ID: 28718029
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey.
Bittoni MA; Focht BC; Clinton SK; Buckworth J; Harris RE
Int J Oncol; 2015 Oct; 47(4):1537-44. PubMed ID: 26323323
[TBL] [Abstract][Full Text] [Related]
33. Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
Izano M; Wei EK; Tai C; Swede H; Gregorich S; Harris TB; Klepin H; Satterfield S; Murphy R; Newman AB; Rubin SM; Braithwaite D;
Int J Cancer; 2016 Mar; 138(5):1118-28. PubMed ID: 26413860
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
35. C-reactive protein and colorectal cancer mortality in U.S. adults.
Goyal A; Terry MB; Jin Z; Siegel AB
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1609-18. PubMed ID: 24867266
[TBL] [Abstract][Full Text] [Related]
36. Clinical Implications of C-Reactive Protein as a Prognostic Marker in Advanced Cancer Patients in Palliative Care Settings.
Amano K; Maeda I; Morita T; Miura T; Inoue S; Ikenaga M; Matsumoto Y; Baba M; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Nagaoka H; Mori M; Kinoshita H
J Pain Symptom Manage; 2016 May; 51(5):860-7. PubMed ID: 26826676
[TBL] [Abstract][Full Text] [Related]
37. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.
Il'yasova D; Colbert LH; Harris TB; Newman AB; Bauer DC; Satterfield S; Kritchevsky SB
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2413-8. PubMed ID: 16214925
[TBL] [Abstract][Full Text] [Related]
38. Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.
Hong T; Liu A; Cai D; Zhang Y; Hua D; Hang X; Wu X
Cancer Invest; 2013 May; 31(4):279-85. PubMed ID: 23627410
[TBL] [Abstract][Full Text] [Related]
39. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.
Frydenberg H; Thune I; Lofterød T; Mortensen ES; Eggen AE; Risberg T; Wist EA; Flote VG; Furberg AS; Wilsgaard T; Akslen LA; McTiernan A
Breast Cancer Res Treat; 2016 Jan; 155(2):345-54. PubMed ID: 26740213
[TBL] [Abstract][Full Text] [Related]
40. C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis.
Zhou B; Liu J; Wang ZM; Xi T
PLoS One; 2012; 7(8):e43075. PubMed ID: 22912790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
